Related Experiment Videos

Umbilical cord androgens in infants of diabetic mothers

O Gemer1, J Sevillia, J Zalis

  • 1Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel.

Insights

Umbilical cord testosterone and androstenedione levels did not differ between infants of mothers with and without diabetes. Fetal weight and insulin levels showed no correlation with these androgen levels in newborns.

Area of Science:

  • Endocrinology
  • Neonatal Health
  • Reproductive Biology

Background:

  • Gestational diabetes mellitus (GDM) can impact fetal development.
  • Androgens play a role in fetal growth and development.
  • Understanding hormonal profiles in infants of diabetic mothers is crucial.

Purpose of the Study:

  • To measure umbilical cord blood concentrations of testosterone and androstenedione.
  • To investigate the relationship between these androgens and fetal weight.
  • To explore correlations with fetal insulin levels in infants of diabetic mothers.

Main Methods:

  • Umbilical venous blood samples were collected at birth.
  • Concentrations of testosterone, androstenedione, and insulin were measured.
  • Infants of 12 gestational diabetic mothers and 12 controls were studied.

Main Results:

  • Mean umbilical cord testosterone and androstenedione levels were comparable between diabetic and control groups.
  • No significant differences in androgen concentrations were observed.
  • Maternal weight, fetal weight, and insulin levels did not correlate with umbilical androgen levels.

Conclusions:

  • Gestational diabetes does not appear to significantly alter umbilical cord androgen levels.
  • Fetal weight and insulin concentrations are not associated with umbilical testosterone or androstenedione.
  • Further research may explore other factors influencing fetal androgen exposure.

Related Concept Videos